Table 3
Comparison reference dose values with NDRLs.
| DRLs | CTDIvol (mGy) | DLP (mGy.cm) | CTDIvol (mGy) | DLP (mGy.cm) | CTDIvol (mGy) | DLP (mGy.cm) |
|---|---|---|---|---|---|---|
| CVA/stroke | Trauma/RTA | Brain tumor/SOL | ||||
| This study Botwe et al. Geryes et al. Tan et al. Foley et al., EU DRLs UKHSA HIQA, (IR) Widmark et al. |
69*** 77 44 42.1 38.8 48 46 – – |
1426* 1413** 1313 850 692 626 807 804 970 – |
69* 63** 77 43 41.2 39 – – – 60 |
1657* 1352** 1596 870 677 908 – – 908 950 |
69*** 82 44 41.3 38.7 45 – – |
1690* 1374** 1390 790 669 – – – – |
| Pulmonary embolism | Lung tumor | Chest lesion with CKD | ||||
| This study Botwe et al. Geryes et al. England, UK UKHSA Aberle et al Lee et al. |
9*** 14 8 10 13 8 – |
366* 344** 491 310 337 440 300 – |
10* 9** 12 5 9 12 – 10 |
359* 324** 467 200 328 610 – 390 |
11*** 13 – – – – – |
375* 330** 467 = – – – – |
| Abdominopelvic lesion | kidney stones | Urothelial malignancy | ||||
| This study Botwe et al. Geryes et al. England, UK Widmark et al. Aberle et al |
12* 10** 17 12 9 11 11 |
580* 523** 694 620 725 800 540 |
11* 10** 14 8 7 – 6 |
542* 519** 731 870 338 – 338 |
14* 12** 11 = – 13 – |
517* 496** 336 790 – 1300 – |
Lee et al=Austria, Geryes et al.=France, Botwe et al.=Ghana, Widmark et al.=Norway, Aberle et al=Australia, Foley et al.=Ireland, HIQA=Ireland, UKHSA=UK, EU=European Union, HIQA= Health Information and Quality Authority, Ireland, UKHSA=UK Health Security Agency. * Values derived from the distribution of pooled data for all centers, ** values derived from 75th percentile of all medians (Table 2), *** values of * and ** are the same.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.